We are a Swiss law firm, dedicated to providing legal solutions to business, tax and regulatory matters.
Dedicated to our clients' success
Services
Intellectual Property
Life Sciences, Pharma, Biotech
Litigation and Arbitration
Meet our team
Our knowledge, expertise & publications
View all
Events
Deals & Cases
Careers
31 December 2013
VISCHER advises Sonetik in a financing to fund further growth in the US. The participants in this Series A2 financing include existing investors, BB Biotech Ventures, and new investors joining the consortium, Aeris Capital. The VISCHER consisted of Matthias Staehelin and Marius Meier (both Corporate).
Categories: Startup Desk, Health Care, Life Sciences, Pharma, Biotech, Private Equity & Venture Capital, Deals & Cases
Attorney at Law and Civil Law Notary (BS/BL)
Swiss dental startup Odne (former Lumendo) has raised USD 5.5m to fund the upcoming US market launch...
Artiria Medical SA, a Swiss neurovascular MedTech company developing next-generation...
GlycoEra AG in Wädenswil, has increased its Series A Financing Round with a substantial additional...